Acorah Software Products - Accounts Production 16.1.300 false true true 28 February 2023 1 March 2022 false 1 March 2023 29 February 2024 29 February 2024 08409943 T G Fraser iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08409943 2023-02-28 08409943 2024-02-29 08409943 2023-03-01 2024-02-29 08409943 frs-core:CurrentFinancialInstruments 2024-02-29 08409943 frs-core:Non-currentFinancialInstruments 2024-02-29 08409943 frs-core:ShareCapital 2024-02-29 08409943 frs-core:RetainedEarningsAccumulatedLosses 2024-02-29 08409943 frs-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 08409943 frs-bus:FilletedAccounts 2023-03-01 2024-02-29 08409943 frs-bus:SmallEntities 2023-03-01 2024-02-29 08409943 frs-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 08409943 frs-bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 08409943 frs-bus:Director1 2023-03-01 2024-02-29 08409943 frs-countries:EnglandWales 2023-03-01 2024-02-29 08409943 2022-02-28 08409943 2023-02-28 08409943 2022-03-01 2023-02-28 08409943 frs-core:CurrentFinancialInstruments 2023-02-28 08409943 frs-core:Non-currentFinancialInstruments 2023-02-28 08409943 frs-core:ShareCapital 2023-02-28 08409943 frs-core:RetainedEarningsAccumulatedLosses 2023-02-28
Registered number: 08409943
Panmedica Medical Distribution Limited
Financial Statements
For The Year Ended 29 February 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 08409943
2024 2023
Notes £ £ £ £
CURRENT ASSETS
Stocks 4 2,641 9,252
Debtors 5 97,271 68,035
Cash at bank and in hand 924 530
100,836 77,817
Creditors: Amounts Falling Due Within One Year 6 (69,221 ) (57,720 )
NET CURRENT ASSETS (LIABILITIES) 31,615 20,097
TOTAL ASSETS LESS CURRENT LIABILITIES 31,615 20,097
Creditors: Amounts Falling Due After More Than One Year 7 (26,183 ) (28,248 )
NET ASSETS/(LIABILITIES) 5,432 (8,151 )
CAPITAL AND RESERVES
Called up share capital 8 200 200
Profit and Loss Account 5,232 (8,351 )
SHAREHOLDERS' FUNDS 5,432 (8,151)
Page 1
Page 2
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
T G Fraser
Director
26 February 2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Panmedica Medical Distribution Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08409943 . The registered office is Leonard House, 5-7 Newman Road, Kent, BR1 1RJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The accounts have been prepared on a going concern basis, which is dependent on the continued support of the director who has indicated his willingness to support the company for the foreseeable future.  The director therefore considers it appropriate to prepare the financial statements on a going concern basis.
2.3. Turnover
Revenue is recognised to the extent that the company obtains the right to consideration in exchange for its performance. Revenue is measured at the fair value of the consideration received, excluding discounts, rebates, VAT and other sales taxes or duty. 
2.4. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
2.5. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
4. Stocks
2024 2023
£ £
Stock 2,641 9,252
Page 3
Page 4
5. Debtors
2024 2023
£ £
Due within one year
Trade debtors 11,726 17,541
Other debtors 85,545 50,494
97,271 68,035
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 5,205 13,266
Bank loans and overdrafts 6,000 10,000
Amounts owed to participating interests 24,761 -
Other creditors 33,255 27,330
Taxation and social security - 7,124
69,221 57,720
7. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans 26,183 28,248
8. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 200 200
9. Directors Advances, Credits and Guarantees
Included within Debtors is a loan to the director of £28,980.
The above loan is unsecured, interest free and repayable on demand.
Page 4